NASDAQ

Quanterix Corporation (QTRX)

607 Thanks from members

Quanterix Corporation (QTRX) faces a sharp market correction and rating downgrades following a severe Q2 earnings miss, lowered 2026 revenue guidance, a $26.9M impairment, and a delayed cash-flow breakeven timeline pushed back to 2027.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →